Viewing nowCombinationTelmidipine Tablet 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 201605761 · Approved 2016.09.30 · Insurance code 657805930
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with telmisartan or amlodipine.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see Section ‘3. Patients Requiring Caution’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication should not be used during pregnancy as it can pose serious risks to the fetus, especially in the second and third trimesters. It should be discontinued as soon as pregnancy is confirmed. This medication should not be administered to patients with hypersensitivity to the active ingredient or similar components, to pregnant or potentially pregnant women, to nursing mothers, to patients with biliary obstructive disease, severe liver impairment, certain heart-related diseases, severe hypotension, patients in shock, and patients with unstable heart failure following acute myocardial infarction. Additionally, patients with primary aldosteronism, certain heart valve diseases, liver impairment, gastrointestinal diseases, renovascular hypertension, dialysis patients, elderly patients, etc., should use this medication cautiously. Common side effects may include dizziness and peripheral edema, and serious side effects such as fainting have been reported rarely. Signs of hypotension may occur if blood pressure drops too low; in case of symptoms, the patient should be laid down immediately and seek medical attention if necessary. It is important to regularly monitor serum potassium levels and kidney function during treatment with this medication, with particular caution for patients with poor kidney function. When used in conjunction with other medications, interactions are possible, so consultation with healthcare personnel is advised, especially when taken with lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs. If pregnant or planning to become pregnant, it is recommended to switch to another antihypertensive medication that has been proven safe instead of this drug. This medication may cause drowsiness or dizziness when driving or operating machinery; caution is advised. In case of overdose, symptoms may include hypotension, tachycardia, dizziness, and acute kidney failure, requiring immediate medical intervention. Keep this medication out of reach of children, and open the packaging just before taking the product.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly closed container that is protected from light. It should also be stored at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness.
White and light blue, biconvex oval double-coated tablet
30 tablets/box [10 tablets/PTP × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.